CIS 2024 Annual Meeting

Welcome to the 2024 Clinical Immunology Society Annual Meeting: Immune Deficiency & Dysregulation North American Conference. The 2024 Annual Meeting will be held in-person in  Minneapolis, Minnesota! On behalf of the Program Committee and CIS leadership, we are excited to welcome attendees to the 2024 Annual Meeting!

The primary goal of the Annual Meeting is to provide a stimulating and lively forum for presentation and discussion of the latest advances in clinical immunology, including primary immunodeficiencies and immune dysregulatory diseases, and related areas, including molecular pathogenesis, and novel therapeutic approaches.

The conference will focus on cutting edge clinical and basic science research, as well as practical applications of these in patient care. The plenary sessions of the conference are specifically designed to tackle key issues facing physicians and scientists in the field of clinical immunology, while also exploring its inter-connectedness to other medical disciplines and healthcare in general, and addressing the challenges and benefits of new diagnostic tools, and therapeutic options currently available for personalized treatment of patients with rare immunological disorders. The sessions will also provide a venue for lively dialogue on the growing field of secondary immunodeficiencies, and the future of immunomodulatory therapies.

The ultimate goal of the Annual CIS meeting is to engage, educate and generate a large and collaborative network of clinical immunology physicians and scientists, in a manner that is consistent with the overarching aims of the Clinical Immunology Society, and equip them for clinical practice and research in this field.

We look forward to seeing you in Minneapolis!

Elie Haddad, MD, PhD CHU Ste-Justine, University of Montreal CIS President 2024 Program Co-Chair	Luigi Notarangelo, MD National Institutes of Health 2024 Program Co-Chair	Emily Mace, PhD Columbia University 2024 Program Co-Chair